Acompanhe as Notícias da Recifes

The lower house of France's parliament adopted bill for assisted dying. But the the government bypassed the right-wing dominated Senate and the law will instead go to the highest constitutional court for final approval.

Building society rules need an overhaul if ballots on executive pay are non-binding and huge takeovers don’t require approval In the end, the rebellion at Nationwide, the country’s biggest building society, was modest. James Sherwin-Smith, who was trying to become the first membe

Parliament adopted the text by 291 votes to 241, though it still needs approval from the Constitutional Council. O recorte ajuda a contextualizar a pauta dentro de Geral.

At the beginning of July 2026, the U.S. Food and Drug Administration approved the first gene therapy for young children with sickle cell disease.

Prime minister’s plan will create energy regulations for datacentres in AustraliaGet our breaking news email, free app or daily news podcastEnvironmental and community groups have called for a pause on datacentre development until new regulations are in place after Anthony Albane

The Nigerian Senate on June 24 approved a bill to allow states to create their own police forces, concerns over the country's myriad conflicts were brought back into the spotlight recently after a mass school abduction in the typically safer southwest. But experts warn that putti

The U.S. Food and Drug Administration has approved an expanded indication for Zoryve (roflumilast) cream, 0.3%, for the topical treatment of plaque psoriasis in patients ages 2 and older. The expanded approval was granted to Arcutis Biotherapeutics.

France’s National Assembly is set to give final approval Wednesday to a bill allowing adults with incurable illnesses to receive lethal medication, the culmination of years of debate over end-of-life care.

The U.S. Food and Drug Administration has granted accelerated approval to Sanofi's Tzield (teplizumab-mzwv) to delay the decline in endogenous insulin production in children aged 8 to 17 years recently diagnosed with stage 3 type 1 diabetes.

The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED). Approval was granted to Viridian Therapeutics.

The U.S. Food and Drug Administration has issued a supplemental approval for Casgevy (exagamglogene autotemcel) for patients ages 2 and older with either sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) or transfusion-dependent β thalassemia (TDT). Supplement

Medicare prescriptions for Wegovy increased sharply after the program started covering the anti-obesity medication to prevent heart problems, but just a fraction of beneficiaries likely eligible received the treatment, according to new research published in the American Journal o